Impact of Platelet Functional Assays on the Cost of Treating Suspected Heparin-Induced Thrombocytopenia

Conclusion:
The use of SRA did not reduce the costs or improve clinical outcomes in patients with suspected HIT.

Source: Journal of Pharmacy Practice - July 19, 2015 Category: Drugs & Pharmacology Authors: Sadik, Z. G., Jennings, D. L., Nemerovski, C. W., Kuriakose, P., Kalus, J. S. Tags: Research Articles Source Type: research